Universidad de Puerto Rico en Arecibo
Departamento de Biología
EXAMEN NO. 2 – BIOL 3705
Fecha:_______________________________________ Sección:_____ Prof. ___________________
Nombre:______________________________________
NO. DE ESTUDIANTE: ________________________
Nombre:______________________________________ ________________________
Nombre:______________________________________
________________________
I. TERMS AND
DEFINITIONS: (14 puntos)
Place the letter of
each term in the space next to the definition or description that best matches
it.
____
1. The ratio of
therapeutic dose to toxic dose
____
2. Compounds used in the treatment of disease
that kill or prevent the growth of microorganisms at
concentrations
low enough to avoid undesirable damage to the host
____ 3. Chemotherapeutic antimicrobial agents that
are natural products of microorganisms
____ 4. Activities of a chemotherapeutic agent that
damage the host either by inhibiting the same
process
in the host as in the target organism or by damaging other processes
____
5. Describes an
antibiotic that attacks many different pathogens
____ 6. Describes an antibiotic that is effective
against only a limited variety of pathogens
____ 7. Antimicrobial drugs that are totally
synthesized by one or more microorganisms
____
8. Antimicrobial drugs
that are artificially synthesized by chemical processes
____
9. Natural antibiotics
that have been chemically modified
____ 10. Lowest concentration of a drug necessary
to prevent the growth of a particular microorganism
____ 11. Lowest concentration of a drug
necessary to kill a particular microorganism
____
12. Drugs that
block the function of metabolic pathways
____ 13. Small circular DNA molecules that can exist
separately from the chromosome or be integrated into it
____ 14. Plasmids that bear one or more
resistance genes
a. antibiotics
b. antimetabolites
c. broad
spectrum drug
d. chemotherapeutic
agent
e. minimal
inhibitory concentration
f. minimal
lethal concentration
g. narrow
spectrum drug
h. natural
antibiotics
i. plasmids
j. R factors
k. semisynthetic antibiotics
1. side effects
m. synthetic
antibiotics
n. therapeutic
index
II. Match the following scientists with
their discoveries. (
8 puntos)
____ 1. Use of the arsenic compound
Salvarsan as a treatment for syphilis a. Chain
b. Domagk
____ 2. Use of Prontosil
Red (sulfanilamide) as a treatment for streptococcal and staphylococcal
infections c. Duchesne
d. Ehrlich
____ 3. First discovered penicillin, but discovery
was lost e. Fleming
____ 4. Rediscovered penicillin, but did not pursue
the significance of it f. Florey g. Heatley
____ 5. Co-discoverer of the
therapeutic value of penicillin h. Waksman
____ 6. Co-discoverer of the therapeutic value of
penicillin
____ 7. Discovered streptomycin and stimulated
intense search for other antibiotics
____ 8. Biochemist who helped with work demonstrating
the therapeutic value of penicillin
III. DRUG ACTION: (36 puntos)
For each
of the drugs usted below indicate: (1) its mechanism
of action (e.g., cell wal1 synthesis inhibitor, cell membrane darnage); (2) whether it is primarily cidal
or static; and (3) what type of organism it is used against (bacteria,
fungi, virus)
Drug Mechanism Cidal/Static Organism
1.Penicillin _________ _________ _________
2.Polymyxin R _________ _________ _________
3.Gentamicin _________ _________ _________
4.Acyclovir _________ _________ _________
5 Flucytosine _________ _________ _________
6. Sulfonamides _________ _________ _________
7. Miconazole _________ _________ _________
8. Rifampin _________ _________ _________
9. Cephalosporins _________ _________ _________
10. Ciprofloxacin _________ _________ _________
11. Tetracyclines _________ _________ _________
12. Isoniazid _________ _________ _________
IV. FILL IN THE
BLANK: (16 puntos)
1. The (1) _____________ is the ratio of the therapeutic
dose to the (2)________dose. The largest is the ratio, the
(3)___________ the chemotherapeutic agent (all other things being equal).
2. A number of useful drugs act as (4 ) ____________;
they block the functioning of metabolic pathways by acting as
(5)_____________ inhibitors of key enzymes.
3. Many forms of penicillin are not suitable for a(n) (6)
_____________ route of administration because they are
relatively unstable in
(7)_____________.
4. Antibiotics
that are taken by mouth are said to have a (n) (8) ____________ route of adininistration; those given by
injection have a (n)
(9) ____________ route of administration; while those applied to the
skin are said to have a (n)
(10) _____________ route of
administration.
5. Sulfonamide is a competitive inhibitor of (11) _____________ synthesis and thereby
causes a reduction in concentration
of this metabolite. Ultimately, this decreases the supply of (12)_____________
and (13) ____________ which are needed
for nucleic acid synthesis. Sulfonamides do not affect
humans because humans do not synthesize (14) ____________ an
must ingest it in their díet.
6. One of die most serious threats to die successful
treatment of disease is the spread of (15) _____________ pathogens. This
problem has been aggravated by (16) ____________ use of antibiotics.
IV.
MULTIPLE CHOICE:
(10 puntos)
For each
of the questions below select the one best answer.
1. Which of the following is not true about
drug 5. Combinations of drugs are often more
side effects? effective because each drug enhances the
a. Side effects may result from drug effect of
the other. This is called
inhibition of the same process in the host a. multiplicity.
as in the target cell. b. synergism.
b. Side effects may result from drug c. complementation.
damage to a different process in the host d. additivity.
cell than in the target cell. 6. Which of the following is not a common
c. Side effects usually result from damage mechanism by which
microorganisms develop
to the host's liver when it attempts to drug resistance?
eliminate the drug from the system. a. enzymatic inactivation of the drug
d. All of the above are true about drug side b. exclusion of the drug from the cell
effects. c. use of an
alternative pathway to bypass
2. In which of the
following cases would the the
drug-sensitive pathway
action of the drug be considered primarily d. All of the above are common
static? mechanisms by which microorganisms
a. The MLC is equal to the MIC. develop drug resistance.
b. The MLC is lower than the MIC. 7. Which of the following is(are)
used to
c. The MLC is 2 to 4 times higher than the discourage the
development of drug
MIC. resistance?
d. The MLC is 10 to 20 times higher than a. sufficiently high drug doses to destroy
the MIC. any resistant mutants that may arise
3. The most selective antibiotics are those that spontaneously
interfere with bacterial cell wall synthesis. b. use of two drugs
simultaneously with the
This is
because hope
that each will prevent the
a. bacterial cell
walls have a unique emergence
of resistance to the other
structure not found in eucaryotic
cells. c. avoidance of indiscriminate
use of drugs
b. bacterial cell
wall synthesis is easy to d. All of the above
are used to discourage
inhibit, while animal cell wall synthesis development
of drug resistance.
is more resistant to the actions of the 8. Which of the following is not a reason that
drugs. treatment of fungal infections generally have
c. animal cells do
not take up the drugs. been less successful than treatment of bacterial
d. animal cells
inactivate the drugs before infections?
they can do any damage. a. Fungi use the metabolic machinery of the
4. Which of the following will not have an
effect host
and therefore cannot be selectively
on the concentration achieved in the blood by attacked.
a particular
antibiotic? b. Fungi are more similar to human cells
a. the route of administration than
are bacteria, and many drugs that
b. the speed of uptake from the site of inhibit
or Itill fungi are toxic for humans.
administration c. Fungi have detoxifying systems that
c. the rate at which the drug is eliminated rapidly
inactivate many drugs.
from the body d. All of the above
are reasons that
d. All
of the above will affect the treatment
of fungal infections has been
concentration of the
drug in the blood. less successful than treatment of bacterial
infections.
9. The drug
level required for the clinical treatment
of a particular infection is called the
a. therapeutic
dose.
b. toxic dose.
c. therapeutic index.
d. None of the above are
correct.
10. Which of the following affects the size of the clear
zone in a disk diffusion test of antimicrobial susceptibility?
a. the initial
concentration of the drug
b. the solubility of the drug
c. the diffusion rate of the drug
d. All of the above are correct.
V.
TRUE / FALSE: (10 puntos) A. TRUE B.
FALSE
____ 1. A drug that disrupts a microbial function
not found in animal cells usually has a lower therapeutic index.
____
2. Static
agents do not kill infectious organisms and therefore are not useful as
chemotherapeutic agents.
____
3. Protein synthesis inhibitors have a high therapeutic index because
they can usually discriminate
between procaryotic and eucaryotic ribosomes.
____ 4. Sulfonamides and other drugs that inhibit
folic acid synthesis have a high therapeutic index because humans must obtain
folic acid in
their
diets while microorganisms synthesize their own.
____ 5. Drugs can
usually penetrate the blood-brain barrier, and therefore, it is easy to treat
nervous system infections, such as
meningitis.
____ 6. The fungus Candida
albicans is normally present in various parts of
the body and causes a problem (superinfection)
only when bacterial
competition is eliminated by antibiotic treatment.
____ 7. Isoniazid is a
narrow-spectrum antibiotic. However, it is considered useful because it is one
of the few drugs that are effective against
tuberculosis.
____
8. Drugs
with highly toxic side effects are usually used only in life-threatening
situations where suitable alternatives
are
not available.
____
9. There
are no effective antiviral drugs because viruses use the metabolic machinery of
their hosts and therefore have
no
selective point of attack.
____ 10. One way in which
organisms may exhibit resistance to a drug is to be able to pump the drug out
of the cell
immediately after it has entered.